Increased rates of CD4(+) and CD8(+) T lymphocyte turnover in simian immunodeficiency virus-infected macaques.

Integrative pathophysiology of solid tumors: role in detection and treatment.

The next frontier of molecular medicine: delivery of therapeutics.

Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor.

Cancer, angiogenesis and fractals.

Delivery of molecular and cellular medicine to solid tumors.

Intratumor pharmacokinetics, flow resistance, and metabolism during gemcitabine infusion in ex vivo perfused human small cell lung cancer.

Primary tumor size-dependent inhibition of angiogenesis at a secondary site: an intravital microscopic study in mice.

Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies.

Effect of tumor necrosis factor alpha on vascular resistance, nitric oxide production, and glucose and oxygen consumption in perfused tissue-isolated human melanoma xenografts.

Return of lymphatic function after flap transfer for acute lymphedema.

Angiogenesis in the huPBL-SCID model of human transplant rejection.

Understanding barriers to drug delivery: high resolution in vivo imaging is key.

Water channel (aquaporin 1) expression and distribution in mammary carcinomas and glioblastomas.

Cellular membrane permeability of anthracyclines does not correlate with their delivery in a tissue-isolated tumor.

Openings between defective endothelial cells explain tumor vessel leakiness.

Vascular permeability in a human tumour xenograft: molecular charge dependence.

Role of extracellular matrix assembly in interstitial transport in solid tumors.

Formation of endothelial cell networks.

Fractals and cancer.

Changes in vascularization of human breast cancer xenografts responding to antiestrogen therapy.

Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation.

Angiogenesis in cancer and other diseases.

Delivery of molecular and cellular medicine to solid tumors.

Clearing the smoke on nicotine and angiogenesis.

Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function.

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.

Transport of molecules, particles, and cells in solid tumors.

Can engineered bacteria help control cancer?

Vessels of death or life.

Comparison of IgG diffusion and extracellular matrix composition in rhabdomyosarcomas grown in mice versus in vitro as spheroids reveals the role of host stromal cells.

Angiogenesis and lymphangiogenesis in tumors: insights from intravital microscopy.

Pharmacokinetics of methotrexate in solid tumors.

Thinning of films with deformable surfaces: diffusion-controlled surfactant transfer

Spontaneous rupture of thin liquid films

Stability of stagnant viscous films on a solid surface

Short term regulation of BOD upsets in an estuary

Dynamics of drug transport in solid tumors: distributed parameter model

Temperature distributions in normal and neoplastic tissues during hyperthermia: a lumped parameter model

Stability of symmetric and unsymmetric, thin liquid films to short and long wavelength perturbations

Incorporating toxicology in the synthesis of industrial chemical complexes

Temperature distributions and thermal response in humans. II. Simulation of whole-body, regional and localized hyperthermia in cancer patients

Effect of glucose, galactose, and transmembrane potential on shear elastic modulus of erythrocyte membrane.

Analysis of diffusive and convective recovery after photobleaching-uniform flow field.

Interstitial transport in tumors.

Drug Delivery: Barriers to Drug Transport and the Design of Novel Therapeutic Agents.

Solid Tumor Barriers to Anticancer Drugs.

Correspondence Regarding Fractals and Cancer.

In Memoriam: Pietro M. Gullino (1919-2001)

Correspondence: PET concerns in bevacizumab treatment